HiWebsite

Website Overview: iedat-project.euopen_in_new

General information

Last Updated: 2024-11-30 (yyyy-mm-dd).

Title: Ataxia Telangiectasia rare genetic disease IEDAT Erydel pivotal phase III study H2020 clinical study

Description: a pivotal phase III study will be conducted and regulatory filing for market authorization of the therapy in EU and USA will be made by 2019

Language: English

Contact information

Email

Social Links

Services and technology that the website used

Vendor

Related Websites